• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Racial Differences in Long-Term Cardiovascular Outcomes: The Need to Move From Description to Action.

作者信息

Nanna Michael G, Peterson Eric D

机构信息

Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.

Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.

出版信息

JACC Cardiovasc Interv. 2020 Jul 13;13(13):1596-1598. doi: 10.1016/j.jcin.2020.05.043.

DOI:10.1016/j.jcin.2020.05.043
PMID:32646702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7338011/
Abstract
摘要

相似文献

1
Racial Differences in Long-Term Cardiovascular Outcomes: The Need to Move From Description to Action.长期心血管结局的种族差异：从描述转向行动的必要性。
JACC Cardiovasc Interv. 2020 Jul 13;13(13):1596-1598. doi: 10.1016/j.jcin.2020.05.043.
2
Racial Disparities in Clinical Characteristics and Outcomes of Women Undergoing Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗的女性患者临床特征及预后的种族差异
Cardiovasc Revasc Med. 2019 Dec;20(12):1039-1042. doi: 10.1016/j.carrev.2019.09.020. Epub 2019 Oct 22.
3
Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention.白人患者和黑人患者经皮冠状动脉介入治疗后的主要不良心血管事件和大出血风险。
J Am Heart Assoc. 2019 Nov 19;8(22):e012874. doi: 10.1161/JAHA.119.012874. Epub 2019 Nov 8.
4
Survival benefit from recent changes in management of men and women with ST-segment elevation myocardial infarction treated with percutaneous coronary interventions.经皮冠状动脉介入治疗的 ST 段抬高心肌梗死患者管理的近期变化带来的生存获益。
Cardiol J. 2019;26(5):459-468. doi: 10.5603/CJ.a2018.0057. Epub 2018 Jun 20.
5
African-American patients are less likely to receive drug-eluting stents during percutaneous coronary intervention.非裔美国患者在经皮冠状动脉介入治疗期间接受药物洗脱支架的可能性较小。
Cardiovasc Revasc Med. 2014 Jun;15(4):214-8. doi: 10.1016/j.carrev.2014.04.003. Epub 2014 Apr 12.
6
Racial difference in cardiovascular outcomes following percutaneous coronary intervention in a public health service patient population.公共卫生服务患者群体经皮冠状动脉介入治疗后心血管结局的种族差异。
J Invasive Cardiol. 2010 Apr;22(4):168-73.
7
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.普拉格雷在经皮冠状动脉介入治疗急性冠脉综合征的非裔美国患者中的应用及临床转归。
Catheter Cardiovasc Interv. 2019 Jul 1;94(1):53-60. doi: 10.1002/ccd.28033. Epub 2019 Jan 17.
8
Sex-based differences in outcomes after percutaneous coronary intervention for acute myocardial infarction: a report from TRANSLATE-ACS.基于性别的急性心肌梗死后经皮冠状动脉介入治疗结局的差异：来自 TRANSLATE-ACS 的报告。
J Am Heart Assoc. 2014 Feb 7;3(1):e000523. doi: 10.1161/JAHA.113.000523.
9
Small-vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus-eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post-Approval studies.男性、女性和少数民族患者在使用铂铬依维莫司洗脱支架后的小血管 PCI 结局：PLATINUM Diversity 和 PROMUS Element Plus 上市后研究的汇总结果。
Catheter Cardiovasc Interv. 2019 Jul 1;94(1):82-90. doi: 10.1002/ccd.28071. Epub 2019 Jan 21.
10
Gender disparity in the use of drug-eluting stents during percutaneous coronary intervention for acute myocardial infarction.急性心肌梗死经皮冠状动脉介入治疗中药物洗脱支架使用的性别差异。
Catheter Cardiovasc Interv. 2015 Aug;86(2):221-8. doi: 10.1002/ccd.25837. Epub 2015 Mar 19.

引用本文的文献

1
Racial and Ethnic Disparities in Statin Adherence: Insights from the All of Us Research Program.他汀类药物依从性方面的种族和族裔差异：来自“我们所有人”研究项目的见解。
medRxiv. 2025 Aug 28:2025.08.26.25334490. doi: 10.1101/2025.08.26.25334490.
2
Effects of Implementing a Standardized Surveillance Program on Cardiac Neurodevelopmental Program Referral Completion.实施标准化监测项目对心脏神经发育项目转诊完成情况的影响。
Pediatr Cardiol. 2024 Apr;45(4):821-828. doi: 10.1007/s00246-024-03425-9. Epub 2024 Feb 28.
3
Statins, Mortality, and Major Adverse Cardiovascular Events Among US Veterans With Chronic Kidney Disease.

本文引用的文献

1
Prognostic Impact of Race in Patients Undergoing PCI: Analysis From 10 Randomized Coronary Stent Trials.种族对接受 PCI 治疗患者的预后影响：来自 10 项随机冠状动脉支架试验的分析。
JACC Cardiovasc Interv. 2020 Jul 13;13(13):1586-1595. doi: 10.1016/j.jcin.2020.04.020.
2
COVID-19 and African Americans.新冠病毒与非裔美国人。
JAMA. 2020 May 19;323(19):1891-1892. doi: 10.1001/jama.2020.6548.
3
Temporal Trends in Racial Differences in 30-Day Readmission and Mortality Rates After Acute Myocardial Infarction Among Medicare Beneficiaries.
他汀类药物、死亡率与伴有慢性肾脏病的美国退伍军人的主要不良心血管事件。
JAMA Netw Open. 2023 Dec 1;6(12):e2346373. doi: 10.1001/jamanetworkopen.2023.46373.
4
Weight variability and cardiovascular outcomes: a systematic review and meta-analysis.体重变化与心血管结局：系统评价和荟萃分析。
Cardiovasc Diabetol. 2023 Jan 9;22(1):5. doi: 10.1186/s12933-022-01735-x.
5
Community-Based Culturally Tailored Education Programs for Black Communities with Cardiovascular Disease, Diabetes, Hypertension, and Stroke: Systematic Review Findings.基于社区的、针对心血管疾病、糖尿病、高血压和中风的黑人群体的文化适应性教育计划：系统评价结果。
J Racial Ethn Health Disparities. 2023 Dec;10(6):2986-3006. doi: 10.1007/s40615-022-01474-5. Epub 2022 Dec 12.
6
Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.在患有 2 型糖尿病和动脉粥样硬化性心血管疾病的患者中使用降脂、降压和降糖药物治疗。
JAMA Netw Open. 2022 Feb 1;5(2):e2148030. doi: 10.1001/jamanetworkopen.2021.48030.
在 Medicare 受益人群中，急性心肌梗死后 30 天再入院率和死亡率的种族差异的时间趋势。
JAMA Cardiol. 2020 Feb 1;5(2):136-145. doi: 10.1001/jamacardio.2019.4845.
4
ARMC 5 Variants and Risk of Hypertension in Blacks: MH- GRID Study.ARMC5 变体与黑人高血压风险：MH-GRID 研究。
J Am Heart Assoc. 2019 Jul 16;8(14):e012508. doi: 10.1161/JAHA.119.012508. Epub 2019 Jul 3.
5
Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry.患者对心血管风险的认知及对他汀类药物的信念与他汀类药物使用的种族差异的关系：来自患者和提供者评估血脂管理登记处的见解。
JAMA Cardiol. 2018 Aug 1;3(8):739-748. doi: 10.1001/jamacardio.2018.1511.
6
Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions.社会经济地位与心血管结局：挑战与干预。
Circulation. 2018 May 15;137(20):2166-2178. doi: 10.1161/CIRCULATIONAHA.117.029652.
7
Trends in Racial/Ethnic and Nativity Disparities in Cardiovascular Health Among Adults Without Prevalent Cardiovascular Disease in the United States, 1988 to 2014.美国无心血管疾病成人中心血管健康的种族/民族和出生差异趋势，1988 年至 2014 年。
Ann Intern Med. 2018 Apr 17;168(8):541-549. doi: 10.7326/M17-0996. Epub 2018 Mar 20.
8
Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association.非裔美国人的心血管健康：美国心脏协会的科学声明。
Circulation. 2017 Nov 21;136(21):e393-e423. doi: 10.1161/CIR.0000000000000534. Epub 2017 Oct 23.
9
Diversity Matters.多样性至关重要。
J Am Coll Cardiol. 2017 Sep 19;70(12):1525-1529. doi: 10.1016/j.jacc.2017.08.003.
10
The Effects of Race and Racial Concordance on Patient-Physician Communication: A Systematic Review of the Literature.种族和种族一致性对医患沟通的影响：文献系统评价。
J Racial Ethn Health Disparities. 2018 Feb;5(1):117-140. doi: 10.1007/s40615-017-0350-4. Epub 2017 Mar 8.